SCHEMBL3436779

SCHEMBL3436779

CN1C[C@H](O)[C@@H](O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL85474 1.00
SCHEMBL16855025 1.00
SCHEMBL5318944 1.00
SCHEMBL1971264 1.00
SCHEMBL3379916 0.86 GLB1 (0.48)
SCHEMBL14426713 0.86 GAA (0.48)
SCHEMBL15599042 0.86 GLB1 (0.48)
SCHEMBL14426706 0.86 GAA (0.48)
SCHEMBL14426708 0.86 GAA (0.48)
SCHEMBL9710932 0.86 GLB1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5872249-A QUATERNIZATION, SALT FORMATION, AMINATION, DEALKYLATION KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1999-02-16 US claimed
US-5675003-A ACTIVITY AGAINST STAPHYLOCOCCUS, ENTEROBACTER KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1997-10-07 US claimed
US-5571909-A ANTIBIOTICS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1996-11-05 US claimed
US-20230287021-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING PROTEGO BIOPHARMA, INC. 2023-09-14 US disclosed
US-20230287021-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING PROTEGO BIOPHARMA, INC. 2023-09-14 US disclosed
EP-4097092-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING Protego Biopharma, Inc. (US) 2022-12-07 EP disclosed
CN-115298168-A Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding 普罗泰格生物制药公司 2022-11-04 CN disclosed
WO-2021263039-A1 AMPK ACTIVATORS KALLYOPE, INC. (US) 2021-12-30 WO disclosed
WO-2021154842-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING PROTEGO BIOPHARMA, INC. (US) 2021-08-05 WO disclosed
EP-3548495-B1 PYRAZOLOPYRIMIDINE DERIVATIVES AS CAM KINASE INHIBITORS GILEAD SCIENCES INC (US) 2021-01-27 EP disclosed
US-10385055-B2 Tricyclic gyrase inhibitors MERCK SHARP & DOHME CORP. (US) 2019-08-20 US disclosed
WO-2007096740-A2 NOVEL CEPHALOSPORINS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2007-08-30 WO disclosed
EP-1643998-B1 DUAL NK1/NK3 ANTAGONISTS FOR TREATING SCHIZOPHRENIA HOFFMANN LA ROCHE (CH) 2007-08-29 EP disclosed
WO-2005002577-A1 DUAL NK1/NK3 ANTAGONISTS FOR TREATING SCHIZOPHRENIA F. HOFFMANN-LA ROCHE AG (CH) 2005-01-13 WO disclosed
US-5872249-A QUATERNIZATION, SALT FORMATION, AMINATION, DEALKYLATION KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1999-02-16 US disclosed
US-5872249-A QUATERNIZATION, SALT FORMATION, AMINATION, DEALKYLATION KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1999-02-16 US disclosed
US-5675003-A ACTIVITY AGAINST STAPHYLOCOCCUS, ENTEROBACTER KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1997-10-07 US disclosed
US-5675003-A ACTIVITY AGAINST STAPHYLOCOCCUS, ENTEROBACTER KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1997-10-07 US disclosed
US-5571909-A ANTIBIOTICS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1996-11-05 US disclosed
US-5571909-A ANTIBIOTICS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1996-11-05 US disclosed